Tianjin Ringpu Bio Tech (300119) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

Based on the latest financial reports, Tianjin Ringpu Bio Tech (300119) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥105.02 Million ≈ $15.37 Million USD) by net assets (CN¥5.15 Billion ≈ $753.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Tianjin Ringpu Bio Tech (300119) defensive interval to measure how many days the company can operate on defensive assets alone.

Tianjin Ringpu Bio Tech - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Tianjin Ringpu Bio Tech's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tianjin Ringpu Bio Tech Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Ringpu Bio Tech ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhejiang Guyuelongshan Shaoxing Wine Co Ltd SHG:600059	-0.006x
Bangkok Chain Hospital Public Company Limited BK:BCH-R	0.032x
Sunflower Pharmaceuticals Group Co Ltd SHE:002737	-0.029x
Zhejiang Zhengguang Industrial Co. Ltd. SHE:301092	N/A
Bio-Thera Solutions Ltd SHG:688177	-0.324x
Jiangsu Yinhe Electronics Co Ltd SHE:002519	-0.009x
TotalEnergies EP Gabon S.A. PA:EC	0.068x
Shunfa Hengye Corp SHE:000631	0.000x

Annual Cash Flow Conversion Efficiency for Tianjin Ringpu Bio Tech (2007–2025)

The table below shows the annual cash flow conversion efficiency of Tianjin Ringpu Bio Tech from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 300119 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.18 Billion ≈ $758.67 Million	CN¥297.53 Million ≈ $43.54 Million	0.057x	-60.94%
2024-12-31	CN¥5.01 Billion ≈ $732.68 Million	CN¥735.55 Million ≈ $107.63 Million	0.147x	+86.64%
2023-12-31	CN¥4.80 Billion ≈ $703.11 Million	CN¥378.20 Million ≈ $55.34 Million	0.079x	-9.04%
2022-12-31	CN¥4.50 Billion ≈ $658.65 Million	CN¥389.49 Million ≈ $56.99 Million	0.087x	-2.22%
2021-12-31	CN¥4.32 Billion ≈ $632.69 Million	CN¥382.63 Million ≈ $55.99 Million	0.088x	-37.64%
2020-12-31	CN¥2.74 Billion ≈ $400.51 Million	CN¥388.44 Million ≈ $56.84 Million	0.142x	-12.80%
2019-12-31	CN¥2.36 Billion ≈ $344.92 Million	CN¥383.61 Million ≈ $56.13 Million	0.163x	+109.80%
2018-12-31	CN¥2.25 Billion ≈ $329.89 Million	CN¥174.88 Million ≈ $25.59 Million	0.078x	+56.93%
2017-12-31	CN¥2.18 Billion ≈ $318.46 Million	CN¥107.57 Million ≈ $15.74 Million	0.049x	-49.89%
2016-12-31	CN¥2.11 Billion ≈ $308.09 Million	CN¥207.67 Million ≈ $30.39 Million	0.099x	-22.55%
2015-12-31	CN¥1.77 Billion ≈ $258.84 Million	CN¥225.27 Million ≈ $32.96 Million	0.127x	+71.20%
2014-12-31	CN¥1.73 Billion ≈ $252.53 Million	CN¥128.37 Million ≈ $18.78 Million	0.074x	+44.29%
2013-12-31	CN¥1.72 Billion ≈ $251.73 Million	CN¥88.68 Million ≈ $12.98 Million	0.052x	-9.05%
2012-12-31	CN¥1.59 Billion ≈ $232.13 Million	CN¥89.92 Million ≈ $13.16 Million	0.057x	-6.07%
2011-12-31	CN¥1.50 Billion ≈ $218.92 Million	CN¥90.29 Million ≈ $13.21 Million	0.060x	-23.68%
2010-12-31	CN¥1.43 Billion ≈ $208.78 Million	CN¥112.82 Million ≈ $16.51 Million	0.079x	-69.09%
2009-12-31	CN¥252.48 Million ≈ $36.95 Million	CN¥64.59 Million ≈ $9.45 Million	0.256x	-6.06%
2008-12-31	CN¥249.97 Million ≈ $36.58 Million	CN¥68.07 Million ≈ $9.96 Million	0.272x	+93.74%
2007-12-31	CN¥136.21 Million ≈ $19.93 Million	CN¥19.15 Million ≈ $2.80 Million	0.141x	--

About Tianjin Ringpu Bio Tech

SHE:300119 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.03 Billion

CN¥7.06 Billion CNY

Market Cap Rank

#8931 Global

#2248 in China

Share Price

CN¥15.20

Change (1 day)

-0.65%

52-Week Range

CN¥15.08 - CN¥23.48

All Time High

CN¥39.94